These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 16280311)

  • 1. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders.
    Nitta Y; Iwatsuki K; Kimura H; Kojima S; Morishima T; Tsuji K; Oono T
    Eur J Dermatol; 2005; 15(6):503-6. PubMed ID: 16280311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
    Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
    J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
    Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
    Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
    Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
    Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
    Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
    Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
    Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders.
    Iwatsuki K; Ohtsuka M; Harada H; Han G; Kaneko F
    Arch Dermatol; 1997 Sep; 133(9):1081-6. PubMed ID: 9301584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma.
    Tokura Y; Ishihara S; Tagawa S; Seo N; Ohshima K; Takigawa M
    J Am Acad Dermatol; 2001 Oct; 45(4):569-78. PubMed ID: 11568749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.